SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1snx'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_I_BEZI518_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	ILE A 571 GLY A 574 PRO A 527 ASN A 592	None	0.92A	1oniG-1snxA: undetectable 1oniI-1snxA: undetectable	1oniG-1snxA: 19.92 1oniI-1snxA: 19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_C_CHDC3271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE III CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 8	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.79A	1v54C-1snxA: 1.3 1v54J-1snxA: undetectable	1v54C-1snxA: 19.44 1v54J-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_P_CHDP4271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE III CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 8	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.80A	1v54P-1snxA: 1.3 1v54W-1snxA: undetectable	1v54P-1snxA: 19.44 1v54W-1snxA: 16.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	ALA A 389 GLY A 441 CYH A 442 ASP A 445 LEU A 489 PHE A 501	None	0.45A	1xkkA-1snxA: 22.7	1xkkA-1snxA: 31.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	ALA A 389 MET A 410 ASP A 445 LEU A 489 ASP A 500 PHE A 501	None	0.86A	1xkkA-1snxA: 22.7	1xkkA-1snxA: 31.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	ALA A 389 MET A 410 GLY A 441 ASP A 445 LEU A 489 PHE A 501	None	0.77A	1xkkA-1snxA: 22.7	1xkkA-1snxA: 31.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	MET A 410 ASP A 445 ARG A 448 LEU A 489 ASP A 500 PHE A 501	None	1.12A	1xkkA-1snxA: 22.7	1xkkA-1snxA: 31.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	MET A 410 GLY A 441 ASP A 445 ARG A 448 LEU A 489 PHE A 501	None	1.07A	1xkkA-1snxA: 22.7	1xkkA-1snxA: 31.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 8	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.79A	2dyrC-1snxA: 0.9 2dyrJ-1snxA: undetectable	2dyrC-1snxA: 19.44 2dyrJ-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 8	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.79A	2dyrP-1snxA: 1.3 2dyrW-1snxA: undetectable	2dyrP-1snxA: 19.44 2dyrW-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.75A	2eikC-1snxA: 2.3 2eikJ-1snxA: undetectable	2eikC-1snxA: 19.44 2eikJ-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 8	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.74A	2eikP-1snxA: 2.5 2eikW-1snxA: 0.0	2eikP-1snxA: 19.44 2eikW-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 8	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.79A	2eilC-1snxA: 1.4 2eilJ-1snxA: undetectable	2eilC-1snxA: 19.44 2eilJ-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 8	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.76A	2eilP-1snxA: undetectable 2eilW-1snxA: undetectable	2eilP-1snxA: 19.44 2eilW-1snxA: 16.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2GQG_A_1N1A501_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	ALA A 389 LYS A 391 MET A 410 VAL A 419 PHE A 437 GLY A 441 LEU A 489	None	0.73A	2gqgA-1snxA: 31.3	2gqgA-1snxA: 41.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITO_A_IREA2020_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	ALA A 389 LYS A 391 LEU A 433 GLY A 441 ASP A 445 LEU A 489	None	0.63A	2itoA-1snxA: 29.8	2itoA-1snxA: 32.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITZ_A_IREA2021_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	VAL A 377 ALA A 389 LYS A 391 GLY A 441 ASP A 445 LEU A 489 ASP A 500	None	0.69A	2itzA-1snxA: 29.8	2itzA-1snxA: 33.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2IVU_A_ZD6A3015_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	3 / 3	ALA A 389 GLY A 441 SER A 499	None	0.46A	2ivuA-1snxA: 22.5	2ivuA-1snxA: 33.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OIQ_A_STIA1001_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 5	VAL A 409 LEU A 413 MET A 438 ARG A 481	None	0.83A	2oiqA-1snxA: 22.4	2oiqA-1snxA: 40.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2P16_A_GG2A298_2 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	3 / 3	ARG A 394 GLU A 395 GLN A 373	None	1.09A	2p16A-1snxA: undetectable	2p16A-1snxA: 22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_A_B49A1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	8 / 12	ILE A 369 VAL A 377 ALA A 389 PHE A 435 MET A 438 GLY A 441 LEU A 489 ASP A 500	None	0.83A	2y7jA-1snxA: 23.8	2y7jA-1snxA: 22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_B_B49B1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	8 / 10	ILE A 369 VAL A 377 ALA A 389 PHE A 435 MET A 438 GLY A 441 LEU A 489 ASP A 500	None	0.83A	2y7jB-1snxA: 24.3	2y7jB-1snxA: 22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	8 / 10	ILE A 369 VAL A 377 ALA A 389 PHE A 435 MET A 438 GLY A 441 ASP A 445 LEU A 489	None	0.68A	2y7jC-1snxA: 24.0	2y7jC-1snxA: 22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_D_B49D1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	8 / 10	ILE A 369 VAL A 377 ALA A 389 PHE A 435 MET A 438 GLY A 441 ASP A 445 LEU A 489	None	0.65A	2y7jD-1snxA: 18.0	2y7jD-1snxA: 22.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2YFX_A_VGHA9000_1 (TYROSINE-PROTEIN KINASE RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 8	ALA A 389 MET A 438 GLY A 441 LEU A 489	None	0.31A	2yfxA-1snxA: 30.2	2yfxA-1snxA: 36.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ZVA_A_1N1A513_1 (TYROSINE-PROTEIN KINASE LYN)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	ALA A 389 LYS A 391 MET A 410 VAL A 419 MET A 438 GLY A 441 LEU A 489	None	0.69A	2zvaA-1snxA: 21.9	2zvaA-1snxA: 41.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_C_CHDC271_0 (CYTOCHROME C OXIDASE SUBUNIT 3)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.74A	3ag2C-1snxA: 2.5	3ag2C-1snxA: 19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.76A	3ag2P-1snxA: 2.0 3ag2W-1snxA: undetectable	3ag2P-1snxA: 19.44 3ag2W-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 8	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.81A	3ag4C-1snxA: undetectable 3ag4J-1snxA: undetectable	3ag4C-1snxA: 19.44 3ag4J-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.79A	3ag4P-1snxA: 2.5 3ag4W-1snxA: undetectable	3ag4P-1snxA: 19.44 3ag4W-1snxA: 16.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3AOX_A_EMHA901_1 (ALK TYROSINE KINASE RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 10	ALA A 389 LYS A 391 VAL A 419 MET A 438 GLY A 441 LEU A 489	None	0.58A	3aoxA-1snxA: 22.6	3aoxA-1snxA: 35.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_C_CHDC271_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.80A	3asnC-1snxA: 1.3 3asnJ-1snxA: undetectable	3asnC-1snxA: 19.44 3asnJ-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASO_C_CHDC271_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 8	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.80A	3asoC-1snxA: undetectable 3asoJ-1snxA: undetectable	3asoC-1snxA: 19.44 3asoJ-1snxA: 16.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_B_FMMB91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	VAL A 377 ALA A 389 LEU A 421 GLY A 441 LEU A 489 ASP A 500 PHE A 501	None	0.70A	3bbtB-1snxA: 24.4	3bbtB-1snxA: 33.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	8 / 12	VAL A 377 ALA A 389 LYS A 391 LEU A 433 GLY A 441 LEU A 489 ASP A 500 PHE A 501	None	0.75A	3bbtD-1snxA: 24.8	3bbtD-1snxA: 33.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_A_NILA600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	5 / 12	ALA A 389 LEU A 418 GLY A 441 HIS A 480 LEU A 489	None	0.41A	3cs9A-1snxA: 22.5	3cs9A-1snxA: 41.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_B_NILB600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	5 / 9	VAL A 377 LYS A 391 VAL A 419 LEU A 489 VAL A 498	None	0.82A	3cs9B-1snxA: 31.2	3cs9B-1snxA: 41.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_D_NILD600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	5 / 12	ALA A 389 LEU A 418 PHE A 437 GLY A 441 HIS A 480	None	0.48A	3cs9D-1snxA: 22.6	3cs9D-1snxA: 41.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K54_A_1N1A1_1 (TYROSINE-PROTEIN KINASE BTK)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	ALA A 389 LYS A 391 MET A 410 VAL A 419 GLY A 441 LEU A 489 SER A 499	None	0.74A	3k54A-1snxA: 24.4	3k54A-1snxA: 53.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MIY_A_B49A1_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	8 / 11	ALA A 389 VAL A 419 PHE A 435 MET A 438 GLY A 441 LEU A 489 SER A 499 ASP A 500	None	0.80A	3miyA-1snxA: 27.7	3miyA-1snxA: 98.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MIY_A_B49A1_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 11	ILE A 369 ALA A 389 LYS A 391 PHE A 437 MET A 438 GLY A 441 LEU A 489	None	0.85A	3miyA-1snxA: 27.7	3miyA-1snxA: 98.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MIY_A_B49A1_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	9 / 11	ILE A 369 ALA A 389 VAL A 419 PHE A 435 PHE A 437 MET A 438 GLY A 441 LEU A 489 SER A 499	None	0.73A	3miyA-1snxA: 27.7	3miyA-1snxA: 98.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MIY_B_B49B2_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	8 / 9	ILE A 369 ALA A 389 LYS A 391 PHE A 435 PHE A 437 MET A 438 GLY A 441 LEU A 489	None	0.75A	3miyB-1snxA: 25.9	3miyB-1snxA: 98.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MIY_B_B49B2_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	8 / 9	ILE A 369 ALA A 389 PHE A 435 PHE A 437 MET A 438 GLY A 441 LEU A 489 SER A 499	None	0.67A	3miyB-1snxA: 25.9	3miyB-1snxA: 98.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OCT_A_1N1A663_1 (TYROSINE-PROTEIN KINASE BTK)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	VAL A 377 ALA A 389 LYS A 391 MET A 410 VAL A 419 GLY A 441 LEU A 489	None	0.68A	3octA-1snxA: 14.9	3octA-1snxA: 56.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OG7_A_032A1_1 (AKAP9-BRAF FUSION PROTEIN)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	5 / 12	ILE A 369 VAL A 377 ALA A 389 LYS A 391 PHE A 501	None	0.58A	3og7A-1snxA: 29.3	3og7A-1snxA: 29.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXZ_A_0LIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	ALA A 389 MET A 410 LEU A 418 VAL A 419 GLY A 441 HIS A 480	None	0.82A	3oxzA-1snxA: 22.4	3oxzA-1snxA: 40.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RGF_A_BAXA465_2 (CYCLIN-DEPENDENT KINASE 8)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LYS A 391 LEU A 413 VAL A 478 LEU A 489	None	0.76A	3rgfA-1snxA: 20.8	3rgfA-1snxA: 26.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TI1_A_B49A299_1 (CYCLIN-DEPENDENT KINASE 2)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 9	ILE A 369 ALA A 389 VAL A 419 PHE A 435 PHE A 437 ASP A 500	None	0.94A	3ti1A-1snxA: 23.7	3ti1A-1snxA: 27.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TI1_A_B49A299_1 (CYCLIN-DEPENDENT KINASE 2)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 9	ILE A 369 ALA A 389 VAL A 419 PHE A 435 PHE A 437 LEU A 489	None	0.63A	3ti1A-1snxA: 23.7	3ti1A-1snxA: 27.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UE4_A_DB8A601_1 (TYROSINE-PROTEIN KINASE ABL1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	ALA A 389 LYS A 391 VAL A 419 PHE A 437 MET A 438 GLY A 441 LEU A 489	None	0.42A	3ue4A-1snxA: 31.5	3ue4A-1snxA: 40.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UG2_A_IREA1_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	8 / 12	VAL A 377 ALA A 389 LYS A 391 LEU A 433 MET A 438 GLY A 441 ASP A 445 LEU A 489	None	0.72A	3ug2A-1snxA: 24.1	3ug2A-1snxA: 32.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 5	LYS A 391 VAL A 419 LEU A 489 ASP A 500	None	0.95A	3wzdA-1snxA: 24.4	3wzdA-1snxA: 33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3X2Q_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.83A	3x2qC-1snxA: 1.3 3x2qJ-1snxA: undetectable	3x2qC-1snxA: 19.44 3x2qJ-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3X2Q_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.85A	3x2qP-1snxA: 2.5 3x2qW-1snxA: undetectable	3x2qP-1snxA: 19.44 3x2qW-1snxA: 16.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4AGD_A_B49A2000_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	5 / 11	ALA A 389 VAL A 419 PHE A 437 GLY A 441 LEU A 489	None	0.51A	4agdA-1snxA: 29.7	4agdA-1snxA: 32.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HJO_A_AQ4A1001_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	VAL A 377 ALA A 389 LYS A 391 GLY A 441 CYH A 442 LEU A 489 ASP A 500	None	0.81A	4hjoA-1snxA: 31.4	4hjoA-1snxA: 31.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HJO_A_AQ4A1001_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	VAL A 377 ALA A 389 LYS A 391 MET A 438 GLY A 441 CYH A 442 LEU A 489	None	0.71A	4hjoA-1snxA: 31.4	4hjoA-1snxA: 31.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4I22_A_IREA9001_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	8 / 12	GLY A 370 VAL A 377 ALA A 389 LYS A 391 LEU A 433 GLY A 441 ASP A 445 LEU A 489	None	0.58A	4i22A-1snxA: 24.4	4i22A-1snxA: 32.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KS8_A_B49A701_1 (SERINE/THREONINE-PRO TEIN KINASE PAK 6)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 10	ILE A 369 ALA A 389 VAL A 419 GLY A 441 LEU A 489 SER A 499 ASP A 500	None	0.70A	4ks8A-1snxA: 24.2	4ks8A-1snxA: 27.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KS8_A_B49A701_1 (SERINE/THREONINE-PRO TEIN KINASE PAK 6)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 10	ILE A 369 ALA A 389 VAL A 419 PHE A 437 GLY A 441 LEU A 489 SER A 499	None	0.60A	4ks8A-1snxA: 24.2	4ks8A-1snxA: 27.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXX_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	VAL A 377 ALA A 389 LYS A 391 VAL A 419 MET A 438 GLY A 441 LEU A 489	None	0.48A	4mxxB-1snxA: 23.7	4mxxB-1snxA: 40.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0S_A_ADNA500_1 (AURORA KINASE A)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 11	GLY A 370 VAL A 377 ALA A 389 LYS A 391 ASN A 487 LEU A 489 ASP A 500	None	0.91A	4o0sA-1snxA: 24.7	4o0sA-1snxA: 29.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QRC_A_0LIA802_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 8	VAL A 377 LYS A 391 HIS A 480 LEU A 489	None	0.83A	4qrcA-1snxA: 29.7	4qrcA-1snxA: 31.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WA9_A_AXIA9000_1 (TYROSINE-PROTEIN KINASE ABL1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 11	ALA A 389 LYS A 391 MET A 438 GLY A 441 ASN A 487 LEU A 489	None	0.99A	4wa9A-1snxA: 27.8	4wa9A-1snxA: 40.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XEY_A_1N1A601_1 (TYROSINE-PROTEIN KINASE ABL1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	8 / 12	VAL A 377 ALA A 389 LYS A 391 MET A 410 VAL A 419 PHE A 437 GLY A 441 LEU A 489	None	0.58A	4xeyA-1snxA: 31.5	4xeyA-1snxA: 30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XEY_B_1N1B601_1 (TYROSINE-PROTEIN KINASE ABL1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	VAL A 377 ALA A 389 LYS A 391 VAL A 419 PHE A 437 GLY A 441 LEU A 489	None	0.41A	4xeyB-1snxA: 13.5	4xeyB-1snxA: 30.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z2E_H_TR6H101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B SYMMETRIZED E-SITE DNA)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	3 / 5	GLY A 372 GLY A 370 GLU A 368	None	0.48A	4z2eA-1snxA: 3.7 4z2eD-1snxA: undetectable	4z2eA-1snxA: 19.92 4z2eD-1snxA: 21.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ZAU_A_YY3A1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	5 / 8	GLY A 370 VAL A 377 ALA A 389 MET A 438 GLY A 441	None	0.70A	4zauA-1snxA: 30.0	4zauA-1snxA: 32.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAC_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 10	VAL A 377 ALA A 389 LYS A 391 MET A 438 GLY A 441 LEU A 489	None	0.47A	5aacA-1snxA: 15.3	5aacA-1snxA: 36.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.89A	5b1aC-1snxA: undetectable 5b1aJ-1snxA: undetectable	5b1aC-1snxA: 19.44 5b1aJ-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_P_CHDP305_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.84A	5b1aP-1snxA: 2.5 5b1aW-1snxA: undetectable	5b1aP-1snxA: 19.44 5b1aW-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.82A	5b1bP-1snxA: 1.3 5b1bW-1snxA: undetectable	5b1bP-1snxA: 19.44 5b1bW-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_C_CHDC307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.84A	5b3sC-1snxA: undetectable 5b3sJ-1snxA: undetectable	5b3sC-1snxA: 19.44 5b3sJ-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.86A	5b3sP-1snxA: 2.5	5b3sP-1snxA: 19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G48_A_1FLA1375_1 (DNA POLYMERASE III SUBUNIT BETA)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 8	LEU A 612 ILE A 590 PRO A 603 LEU A 608	None	0.88A	5g48A-1snxA: undetectable	5g48A-1snxA: 22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5I9Y_A_1N1A1001_1 (EPHRIN TYPE-A RECEPTOR 2)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	ILE A 369 ALA A 389 LYS A 391 GLY A 441 LEU A 489 SER A 499	None	0.64A	5i9yA-1snxA: 24.8	5i9yA-1snxA: 39.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_C_CHDC307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.85A	5iy5C-1snxA: undetectable 5iy5J-1snxA: undetectable	5iy5C-1snxA: 19.58 5iy5J-1snxA: 14.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	GLY A 370 VAL A 377 ALA A 389 VAL A 419 PHE A 435 LEU A 489	None	0.50A	5l2iA-1snxA: 8.4	5l2iA-1snxA: 27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENT KINASE 6)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	GLY A 370 VAL A 377 ALA A 389 VAL A 419 PHE A 435 LEU A 489	None	0.86A	5l2tA-1snxA: 8.5	5l2tA-1snxA: 27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MO4_A_NILA601_2 (TYROSINE-PROTEIN KINASE ABL1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	5 / 12	ALA A 389 LEU A 418 VAL A 419 HIS A 480 LEU A 489	None	0.64A	5mo4A-1snxA: 25.2	5mo4A-1snxA: 26.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5P9I_A_1E8A701_1 (TYROSINE-PROTEIN KINASE BTK)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	VAL A 377 ALA A 389 GLY A 441 LEU A 489 SER A 499 PHE A 501	None	0.61A	5p9iA-1snxA: 25.8	5p9iA-1snxA: 54.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TE0_A_XINA401_1 (AP2-ASSOCIATED PROTEIN KINASE 1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	LEU A 379 ALA A 389 VAL A 419 PHE A 437 GLY A 441 LEU A 489	None	0.53A	5te0A-1snxA: 23.2	5te0A-1snxA: 23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TE0_A_XINA401_1 (AP2-ASSOCIATED PROTEIN KINASE 1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	LEU A 379 MET A 410 VAL A 419 PHE A 437 GLY A 441 LEU A 489	None	0.76A	5te0A-1snxA: 23.2	5te0A-1snxA: 23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_2 (WEE1-LIKE PROTEIN KINASE)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 4	VAL A 377 LYS A 391 VAL A 419 ASN A 487	None	1.22A	5vc3A-1snxA: 23.9	5vc3A-1snxA: 22.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_A_1E8A1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	GLY A 370 VAL A 377 ALA A 389 LYS A 391 LEU A 433 CYH A 442 LEU A 489	None	0.77A	5yu9A-1snxA: 24.1	5yu9A-1snxA: 16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_B_1E8B1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	GLY A 370 VAL A 377 ALA A 389 LEU A 433 CYH A 442 ASP A 445 LEU A 489	None	0.73A	5yu9B-1snxA: 24.5	5yu9B-1snxA: 16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_B_1E8B1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	VAL A 377 ALA A 389 LEU A 433 CYH A 442 ASP A 445 LEU A 489 ASP A 500	None	0.78A	5yu9B-1snxA: 24.5	5yu9B-1snxA: 16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_C_1E8C1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	VAL A 377 ALA A 389 LYS A 391 LEU A 433 GLY A 441 ASP A 445 ASP A 500	None	0.93A	5yu9C-1snxA: 22.6	5yu9C-1snxA: 16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_C_1E8C1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	VAL A 377 ALA A 389 LYS A 391 LEU A 433 GLY A 441 CYH A 442 ASP A 445	None	0.83A	5yu9C-1snxA: 22.6	5yu9C-1snxA: 16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_D_1E8D1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	7 / 12	VAL A 377 ALA A 389 GLY A 441 CYH A 442 ASP A 445 LEU A 489 ASP A 500	None	0.63A	5yu9D-1snxA: 23.0	5yu9D-1snxA: 16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_D_1E8D1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	6 / 12	VAL A 377 ALA A 389 LYS A 391 CYH A 442 ASP A 445 ASP A 500	None	0.91A	5yu9D-1snxA: 23.0	5yu9D-1snxA: 16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z84_C_CHDC307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.84A	5z84C-1snxA: undetectable 5z84J-1snxA: undetectable	5z84C-1snxA: 19.44 5z84J-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z85_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.87A	5z85C-1snxA: 0.8 5z85J-1snxA: undetectable	5z85C-1snxA: 19.44 5z85J-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCO_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.88A	5zcoC-1snxA: 2.1 5zcoJ-1snxA: undetectable	5zcoC-1snxA: 19.44 5zcoJ-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCQ_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.84A	5zcqC-1snxA: 2.4 5zcqJ-1snxA: undetectable	5zcqC-1snxA: 19.44 5zcqJ-1snxA: 16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCQ_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 7	LEU A 418 GLN A 420 PHE A 501 LEU A 473	None	0.88A	5zcqP-1snxA: 1.4 5zcqW-1snxA: undetectable	5zcqP-1snxA: 19.44 5zcqW-1snxA: 16.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FNM_A_1N1A1001_1 (-)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	8 / 12	ILE A 369 VAL A 377 ALA A 389 LYS A 391 MET A 438 GLY A 441 LEU A 489 SER A 499	None	0.89A	6fnmA-1snxA: 24.9	6fnmA-1snxA: 38.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_A_STIA604_1 (TYROSINE-PROTEIN KINASE ABL1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 5	VAL A 409 PHE A 437 MET A 438 GLY A 441	None	0.72A	6hd4A-1snxA: 29.5	6hd4A-1snxA: 11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_B_STIB602_1 (TYROSINE-PROTEIN KINASE ABL1)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 6	VAL A 409 PHE A 437 MET A 438 GLY A 441	None	0.76A	6hd4B-1snxA: 29.5	6hd4B-1snxA: 11.15

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1ONI_I_BEZI518_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"ILE A 571;GLY A 574;PRO A 527;ASN A 592","None","0.92A","1oniG-1snxA:undetectable;1oniI-1snxA:undetectable","1oniG-1snxA:19.92;1oniI-1snxA:19.92"],["1V54_C_CHDC3271_0","CYTOCHROME C OXIDASE POLYPEPTIDE III;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.79A","1v54C-1snxA:1.3;1v54J-1snxA:undetectable","1v54C-1snxA:19.44;1v54J-1snxA:16.92"],["1V54_P_CHDP4271_0","CYTOCHROME C OXIDASE POLYPEPTIDE III;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.80A","1v54P-1snxA:1.3;1v54W-1snxA:undetectable","1v54P-1snxA:19.44;1v54W-1snxA:16.92"],["1XKK_A_FMMA91_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"ALA A 389;GLY A 441;CYH A 442;ASP A 445;LEU A 489;PHE A 501","None","0.45A","1xkkA-1snxA:22.7","1xkkA-1snxA:31.23"],["1XKK_A_FMMA91_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"ALA A 389;MET A 410;ASP A 445;LEU A 489;ASP A 500;PHE A 501","None","0.86A","1xkkA-1snxA:22.7","1xkkA-1snxA:31.23"],["1XKK_A_FMMA91_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"ALA A 389;MET A 410;GLY A 441;ASP A 445;LEU A 489;PHE A 501","None","0.77A","1xkkA-1snxA:22.7","1xkkA-1snxA:31.23"],["1XKK_A_FMMA91_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"MET A 410;ASP A 445;ARG A 448;LEU A 489;ASP A 500;PHE A 501","None","1.12A","1xkkA-1snxA:22.7","1xkkA-1snxA:31.23"],["1XKK_A_FMMA91_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"MET A 410;GLY A 441;ASP A 445;ARG A 448;LEU A 489;PHE A 501","None","1.07A","1xkkA-1snxA:22.7","1xkkA-1snxA:31.23"],["2DYR_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.79A","2dyrC-1snxA:0.9;2dyrJ-1snxA:undetectable","2dyrC-1snxA:19.44;2dyrJ-1snxA:16.92"],["2DYR_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.79A","2dyrP-1snxA:1.3;2dyrW-1snxA:undetectable","2dyrP-1snxA:19.44;2dyrW-1snxA:16.92"],["2EIK_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.75A","2eikC-1snxA:2.3;2eikJ-1snxA:undetectable","2eikC-1snxA:19.44;2eikJ-1snxA:16.92"],["2EIK_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.74A","2eikP-1snxA:2.5;2eikW-1snxA:0.0","2eikP-1snxA:19.44;2eikW-1snxA:16.92"],["2EIL_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.79A","2eilC-1snxA:1.4;2eilJ-1snxA:undetectable","2eilC-1snxA:19.44;2eilJ-1snxA:16.92"],["2EIL_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.76A","2eilP-1snxA:undetectable;2eilW-1snxA:undetectable","2eilP-1snxA:19.44;2eilW-1snxA:16.92"],["2GQG_A_1N1A501_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"ALA A 389;LYS A 391;MET A 410;VAL A 419;PHE A 437;GLY A 441;LEU A 489","None","0.73A","2gqgA-1snxA:31.3","2gqgA-1snxA:41.58"],["2ITO_A_IREA2020_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"ALA A 389;LYS A 391;LEU A 433;GLY A 441;ASP A 445;LEU A 489","None","0.63A","2itoA-1snxA:29.8","2itoA-1snxA:32.41"],["2ITZ_A_IREA2021_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"VAL A 377;ALA A 389;LYS A 391;GLY A 441;ASP A 445;LEU A 489;ASP A 500","None","0.69A","2itzA-1snxA:29.8","2itzA-1snxA:33.13"],["2IVU_A_ZD6A3015_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",3,"ALA A 389;GLY A 441;SER A 499","None","0.46A","2ivuA-1snxA:22.5","2ivuA-1snxA:33.44"],["2OIQ_A_STIA1001_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"VAL A 409;LEU A 413;MET A 438;ARG A 481","None","0.83A","2oiqA-1snxA:22.4","2oiqA-1snxA:40.07"],["2P16_A_GG2A298_2","COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR)","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",3,"ARG A 394;GLU A 395;GLN A 373","None","1.09A","2p16A-1snxA:undetectable","2p16A-1snxA:22.78"],["2Y7J_A_B49A1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",8,"ILE A 369;VAL A 377;ALA A 389;PHE A 435;MET A 438;GLY A 441;LEU A 489;ASP A 500","None","0.83A","2y7jA-1snxA:23.8","2y7jA-1snxA:22.83"],["2Y7J_B_B49B1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",8,"ILE A 369;VAL A 377;ALA A 389;PHE A 435;MET A 438;GLY A 441;LEU A 489;ASP A 500","None","0.83A","2y7jB-1snxA:24.3","2y7jB-1snxA:22.83"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",8,"ILE A 369;VAL A 377;ALA A 389;PHE A 435;MET A 438;GLY A 441;ASP A 445;LEU A 489","None","0.68A","2y7jC-1snxA:24.0","2y7jC-1snxA:22.83"],["2Y7J_D_B49D1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",8,"ILE A 369;VAL A 377;ALA A 389;PHE A 435;MET A 438;GLY A 441;ASP A 445;LEU A 489","None","0.65A","2y7jD-1snxA:18.0","2y7jD-1snxA:22.83"],["2YFX_A_VGHA9000_1","TYROSINE-PROTEIN KINASE RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"ALA A 389;MET A 438;GLY A 441;LEU A 489","None","0.31A","2yfxA-1snxA:30.2","2yfxA-1snxA:36.42"],["2ZVA_A_1N1A513_1","TYROSINE-PROTEIN KINASE LYN","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"ALA A 389;LYS A 391;MET A 410;VAL A 419;MET A 438;GLY A 441;LEU A 489","None","0.69A","2zvaA-1snxA:21.9","2zvaA-1snxA:41.52"],["3AG2_C_CHDC271_0","CYTOCHROME C OXIDASE SUBUNIT 3","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.74A","3ag2C-1snxA:2.5","3ag2C-1snxA:19.44"],["3AG2_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.76A","3ag2P-1snxA:2.0;3ag2W-1snxA:undetectable","3ag2P-1snxA:19.44;3ag2W-1snxA:16.92"],["3AG4_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.81A","3ag4C-1snxA:undetectable;3ag4J-1snxA:undetectable","3ag4C-1snxA:19.44;3ag4J-1snxA:16.92"],["3AG4_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.79A","3ag4P-1snxA:2.5;3ag4W-1snxA:undetectable","3ag4P-1snxA:19.44;3ag4W-1snxA:16.92"],["3AOX_A_EMHA901_1","ALK TYROSINE KINASE RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"ALA A 389;LYS A 391;VAL A 419;MET A 438;GLY A 441;LEU A 489","None","0.58A","3aoxA-1snxA:22.6","3aoxA-1snxA:35.19"],["3ASN_C_CHDC271_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.80A","3asnC-1snxA:1.3;3asnJ-1snxA:undetectable","3asnC-1snxA:19.44;3asnJ-1snxA:16.92"],["3ASO_C_CHDC271_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.80A","3asoC-1snxA:undetectable;3asoJ-1snxA:undetectable","3asoC-1snxA:19.44;3asoJ-1snxA:16.92"],["3BBT_B_FMMB91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"VAL A 377;ALA A 389;LEU A 421;GLY A 441;LEU A 489;ASP A 500;PHE A 501","None","0.70A","3bbtB-1snxA:24.4","3bbtB-1snxA:33.13"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",8,"VAL A 377;ALA A 389;LYS A 391;LEU A 433;GLY A 441;LEU A 489;ASP A 500;PHE A 501","None","0.75A","3bbtD-1snxA:24.8","3bbtD-1snxA:33.13"],["3CS9_A_NILA600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",5,"ALA A 389;LEU A 418;GLY A 441;HIS A 480;LEU A 489","None","0.41A","3cs9A-1snxA:22.5","3cs9A-1snxA:41.73"],["3CS9_B_NILB600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",5,"VAL A 377;LYS A 391;VAL A 419;LEU A 489;VAL A 498","None","0.82A","3cs9B-1snxA:31.2","3cs9B-1snxA:41.73"],["3CS9_D_NILD600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",5,"ALA A 389;LEU A 418;PHE A 437;GLY A 441;HIS A 480","None","0.48A","3cs9D-1snxA:22.6","3cs9D-1snxA:41.73"],["3K54_A_1N1A1_1","TYROSINE-PROTEIN KINASE BTK","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"ALA A 389;LYS A 391;MET A 410;VAL A 419;GLY A 441;LEU A 489;SER A 499","None","0.74A","3k54A-1snxA:24.4","3k54A-1snxA:53.00"],["3MIY_A_B49A1_1","TYROSINE-PROTEIN KINASE ITK\/TSK","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",8,"ALA A 389;VAL A 419;PHE A 435;MET A 438;GLY A 441;LEU A 489;SER A 499;ASP A 500","None","0.80A","3miyA-1snxA:27.7","3miyA-1snxA:98.86"],["3MIY_A_B49A1_1","TYROSINE-PROTEIN KINASE ITK\/TSK","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"ILE A 369;ALA A 389;LYS A 391;PHE A 437;MET A 438;GLY A 441;LEU A 489","None","0.85A","3miyA-1snxA:27.7","3miyA-1snxA:98.86"],["3MIY_A_B49A1_1","TYROSINE-PROTEIN KINASE ITK\/TSK","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",9,"ILE A 369;ALA A 389;VAL A 419;PHE A 435;PHE A 437;MET A 438;GLY A 441;LEU A 489;SER A 499","None","0.73A","3miyA-1snxA:27.7","3miyA-1snxA:98.86"],["3MIY_B_B49B2_1","TYROSINE-PROTEIN KINASE ITK\/TSK","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",8,"ILE A 369;ALA A 389;LYS A 391;PHE A 435;PHE A 437;MET A 438;GLY A 441;LEU A 489","None","0.75A","3miyB-1snxA:25.9","3miyB-1snxA:98.86"],["3MIY_B_B49B2_1","TYROSINE-PROTEIN KINASE ITK\/TSK","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",8,"ILE A 369;ALA A 389;PHE A 435;PHE A 437;MET A 438;GLY A 441;LEU A 489;SER A 499","None","0.67A","3miyB-1snxA:25.9","3miyB-1snxA:98.86"],["3OCT_A_1N1A663_1","TYROSINE-PROTEIN KINASE BTK","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"VAL A 377;ALA A 389;LYS A 391;MET A 410;VAL A 419;GLY A 441;LEU A 489","None","0.68A","3octA-1snxA:14.9","3octA-1snxA:56.72"],["3OG7_A_032A1_1","AKAP9-BRAF FUSION PROTEIN","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",5,"ILE A 369;VAL A 377;ALA A 389;LYS A 391;PHE A 501","None","0.58A","3og7A-1snxA:29.3","3og7A-1snxA:29.10"],["3OXZ_A_0LIA1_1","TYROSINE-PROTEIN KINASE ABL1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"ALA A 389;MET A 410;LEU A 418;VAL A 419;GLY A 441;HIS A 480","None","0.82A","3oxzA-1snxA:22.4","3oxzA-1snxA:40.99"],["3RGF_A_BAXA465_2","CYCLIN-DEPENDENT KINASE 8","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LYS A 391;LEU A 413;VAL A 478;LEU A 489","None","0.76A","3rgfA-1snxA:20.8","3rgfA-1snxA:26.74"],["3TI1_A_B49A299_1","CYCLIN-DEPENDENT KINASE 2","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"ILE A 369;ALA A 389;VAL A 419;PHE A 435;PHE A 437;ASP A 500","None","0.94A","3ti1A-1snxA:23.7","3ti1A-1snxA:27.42"],["3TI1_A_B49A299_1","CYCLIN-DEPENDENT KINASE 2","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"ILE A 369;ALA A 389;VAL A 419;PHE A 435;PHE A 437;LEU A 489","None","0.63A","3ti1A-1snxA:23.7","3ti1A-1snxA:27.42"],["3UE4_A_DB8A601_1","TYROSINE-PROTEIN KINASE ABL1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"ALA A 389;LYS A 391;VAL A 419;PHE A 437;MET A 438;GLY A 441;LEU A 489","None","0.42A","3ue4A-1snxA:31.5","3ue4A-1snxA:40.42"],["3UG2_A_IREA1_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",8,"VAL A 377;ALA A 389;LYS A 391;LEU A 433;MET A 438;GLY A 441;ASP A 445;LEU A 489","None","0.72A","3ug2A-1snxA:24.1","3ug2A-1snxA:32.02"],["3WZD_A_LEVA1201_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LYS A 391;VAL A 419;LEU A 489;ASP A 500","None","0.95A","3wzdA-1snxA:24.4","3wzdA-1snxA:33.33"],["3X2Q_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.83A","3x2qC-1snxA:1.3;3x2qJ-1snxA:undetectable","3x2qC-1snxA:19.44;3x2qJ-1snxA:16.92"],["3X2Q_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.85A","3x2qP-1snxA:2.5;3x2qW-1snxA:undetectable","3x2qP-1snxA:19.44;3x2qW-1snxA:16.92"],["4AGD_A_B49A2000_1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",5,"ALA A 389;VAL A 419;PHE A 437;GLY A 441;LEU A 489","None","0.51A","4agdA-1snxA:29.7","4agdA-1snxA:32.81"],["4HJO_A_AQ4A1001_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"VAL A 377;ALA A 389;LYS A 391;GLY A 441;CYH A 442;LEU A 489;ASP A 500","None","0.81A","4hjoA-1snxA:31.4","4hjoA-1snxA:31.74"],["4HJO_A_AQ4A1001_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"VAL A 377;ALA A 389;LYS A 391;MET A 438;GLY A 441;CYH A 442;LEU A 489","None","0.71A","4hjoA-1snxA:31.4","4hjoA-1snxA:31.74"],["4I22_A_IREA9001_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",8,"GLY A 370;VAL A 377;ALA A 389;LYS A 391;LEU A 433;GLY A 441;ASP A 445;LEU A 489","None","0.58A","4i22A-1snxA:24.4","4i22A-1snxA:32.93"],["4KS8_A_B49A701_1","SERINE\/THREONINE-PROTEIN KINASE PAK 6","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"ILE A 369;ALA A 389;VAL A 419;GLY A 441;LEU A 489;SER A 499;ASP A 500","None","0.70A","4ks8A-1snxA:24.2","4ks8A-1snxA:27.96"],["4KS8_A_B49A701_1","SERINE\/THREONINE-PROTEIN KINASE PAK 6","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"ILE A 369;ALA A 389;VAL A 419;PHE A 437;GLY A 441;LEU A 489;SER A 499","None","0.60A","4ks8A-1snxA:24.2","4ks8A-1snxA:27.96"],["4MXX_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"VAL A 377;ALA A 389;LYS A 391;VAL A 419;MET A 438;GLY A 441;LEU A 489","None","0.48A","4mxxB-1snxA:23.7","4mxxB-1snxA:40.07"],["4O0S_A_ADNA500_1","AURORA KINASE A","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"GLY A 370;VAL A 377;ALA A 389;LYS A 391;ASN A 487;LEU A 489;ASP A 500","None","0.91A","4o0sA-1snxA:24.7","4o0sA-1snxA:29.53"],["4QRC_A_0LIA802_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"VAL A 377;LYS A 391;HIS A 480;LEU A 489","None","0.83A","4qrcA-1snxA:29.7","4qrcA-1snxA:31.79"],["4WA9_A_AXIA9000_1","TYROSINE-PROTEIN KINASE ABL1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"ALA A 389;LYS A 391;MET A 438;GLY A 441;ASN A 487;LEU A 489","None","0.99A","4wa9A-1snxA:27.8","4wa9A-1snxA:40.56"],["4XEY_A_1N1A601_1","TYROSINE-PROTEIN KINASE ABL1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",8,"VAL A 377;ALA A 389;LYS A 391;MET A 410;VAL A 419;PHE A 437;GLY A 441;LEU A 489","None","0.58A","4xeyA-1snxA:31.5","4xeyA-1snxA:30.62"],["4XEY_B_1N1B601_1","TYROSINE-PROTEIN KINASE ABL1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"VAL A 377;ALA A 389;LYS A 391;VAL A 419;PHE A 437;GLY A 441;LEU A 489","None","0.41A","4xeyB-1snxA:13.5","4xeyB-1snxA:30.62"],["4Z2E_H_TR6H101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;SYMMETRIZED E-SITE DNA","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",3,"GLY A 372;GLY A 370;GLU A 368","None","0.48A","4z2eA-1snxA:3.7;4z2eD-1snxA:undetectable","4z2eA-1snxA:19.92;4z2eD-1snxA:21.31"],["4ZAU_A_YY3A1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",5,"GLY A 370;VAL A 377;ALA A 389;MET A 438;GLY A 441","None","0.70A","4zauA-1snxA:30.0","4zauA-1snxA:32.42"],["5AAC_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"VAL A 377;ALA A 389;LYS A 391;MET A 438;GLY A 441;LEU A 489","None","0.47A","5aacA-1snxA:15.3","5aacA-1snxA:36.42"],["5B1A_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.89A","5b1aC-1snxA:undetectable;5b1aJ-1snxA:undetectable","5b1aC-1snxA:19.44;5b1aJ-1snxA:16.92"],["5B1A_P_CHDP305_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.84A","5b1aP-1snxA:2.5;5b1aW-1snxA:undetectable","5b1aP-1snxA:19.44;5b1aW-1snxA:16.92"],["5B1B_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.82A","5b1bP-1snxA:1.3;5b1bW-1snxA:undetectable","5b1bP-1snxA:19.44;5b1bW-1snxA:16.92"],["5B3S_C_CHDC307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.84A","5b3sC-1snxA:undetectable;5b3sJ-1snxA:undetectable","5b3sC-1snxA:19.44;5b3sJ-1snxA:16.92"],["5B3S_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.86A","5b3sP-1snxA:2.5","5b3sP-1snxA:19.44"],["5G48_A_1FLA1375_1","DNA POLYMERASE III SUBUNIT BETA","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 612;ILE A 590;PRO A 603;LEU A 608","None","0.88A","5g48A-1snxA:undetectable","5g48A-1snxA:22.22"],["5I9Y_A_1N1A1001_1","EPHRIN TYPE-A RECEPTOR 2","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"ILE A 369;ALA A 389;LYS A 391;GLY A 441;LEU A 489;SER A 499","None","0.64A","5i9yA-1snxA:24.8","5i9yA-1snxA:39.20"],["5IY5_C_CHDC307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.85A","5iy5C-1snxA:undetectable;5iy5J-1snxA:undetectable","5iy5C-1snxA:19.58;5iy5J-1snxA:14.11"],["5L2I_A_LQQA900_1","CYCLIN-DEPENDENT KINASE 6","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"GLY A 370;VAL A 377;ALA A 389;VAL A 419;PHE A 435;LEU A 489","None","0.50A","5l2iA-1snxA:8.4","5l2iA-1snxA:27.30"],["5L2T_A_6ZZA900_1","CYCLIN-DEPENDENT KINASE 6","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"GLY A 370;VAL A 377;ALA A 389;VAL A 419;PHE A 435;LEU A 489","None","0.86A","5l2tA-1snxA:8.5","5l2tA-1snxA:27.30"],["5MO4_A_NILA601_2","TYROSINE-PROTEIN KINASE ABL1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",5,"ALA A 389;LEU A 418;VAL A 419;HIS A 480;LEU A 489","None","0.64A","5mo4A-1snxA:25.2","5mo4A-1snxA:26.06"],["5P9I_A_1E8A701_1","TYROSINE-PROTEIN KINASE BTK","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"VAL A 377;ALA A 389;GLY A 441;LEU A 489;SER A 499;PHE A 501","None","0.61A","5p9iA-1snxA:25.8","5p9iA-1snxA:54.12"],["5TE0_A_XINA401_1","AP2-ASSOCIATED PROTEIN KINASE 1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"LEU A 379;ALA A 389;VAL A 419;PHE A 437;GLY A 441;LEU A 489","None","0.53A","5te0A-1snxA:23.2","5te0A-1snxA:23.50"],["5TE0_A_XINA401_1","AP2-ASSOCIATED PROTEIN KINASE 1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"LEU A 379;MET A 410;VAL A 419;PHE A 437;GLY A 441;LEU A 489","None","0.76A","5te0A-1snxA:23.2","5te0A-1snxA:23.50"],["5VC3_A_DB8A601_2","WEE1-LIKE PROTEIN KINASE","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"VAL A 377;LYS A 391;VAL A 419;ASN A 487","None","1.22A","5vc3A-1snxA:23.9","5vc3A-1snxA:22.82"],["5YU9_A_1E8A1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"GLY A 370;VAL A 377;ALA A 389;LYS A 391;LEU A 433;CYH A 442;LEU A 489","None","0.77A","5yu9A-1snxA:24.1","5yu9A-1snxA:16.00"],["5YU9_B_1E8B1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"GLY A 370;VAL A 377;ALA A 389;LEU A 433;CYH A 442;ASP A 445;LEU A 489","None","0.73A","5yu9B-1snxA:24.5","5yu9B-1snxA:16.00"],["5YU9_B_1E8B1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"VAL A 377;ALA A 389;LEU A 433;CYH A 442;ASP A 445;LEU A 489;ASP A 500","None","0.78A","5yu9B-1snxA:24.5","5yu9B-1snxA:16.00"],["5YU9_C_1E8C1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"VAL A 377;ALA A 389;LYS A 391;LEU A 433;GLY A 441;ASP A 445;ASP A 500","None","0.93A","5yu9C-1snxA:22.6","5yu9C-1snxA:16.00"],["5YU9_C_1E8C1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"VAL A 377;ALA A 389;LYS A 391;LEU A 433;GLY A 441;CYH A 442;ASP A 445","None","0.83A","5yu9C-1snxA:22.6","5yu9C-1snxA:16.00"],["5YU9_D_1E8D1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",7,"VAL A 377;ALA A 389;GLY A 441;CYH A 442;ASP A 445;LEU A 489;ASP A 500","None","0.63A","5yu9D-1snxA:23.0","5yu9D-1snxA:16.00"],["5YU9_D_1E8D1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",6,"VAL A 377;ALA A 389;LYS A 391;CYH A 442;ASP A 445;ASP A 500","None","0.91A","5yu9D-1snxA:23.0","5yu9D-1snxA:16.00"],["5Z84_C_CHDC307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.84A","5z84C-1snxA:undetectable;5z84J-1snxA:undetectable","5z84C-1snxA:19.44;5z84J-1snxA:16.92"],["5Z85_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.87A","5z85C-1snxA:0.8;5z85J-1snxA:undetectable","5z85C-1snxA:19.44;5z85J-1snxA:16.92"],["5ZCO_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.88A","5zcoC-1snxA:2.1;5zcoJ-1snxA:undetectable","5zcoC-1snxA:19.44;5zcoJ-1snxA:16.92"],["5ZCQ_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.84A","5zcqC-1snxA:2.4;5zcqJ-1snxA:undetectable","5zcqC-1snxA:19.44;5zcqJ-1snxA:16.92"],["5ZCQ_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"LEU A 418;GLN A 420;PHE A 501;LEU A 473","None","0.88A","5zcqP-1snxA:1.4;5zcqW-1snxA:undetectable","5zcqP-1snxA:19.44;5zcqW-1snxA:16.92"],["6FNM_A_1N1A1001_1","-","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",8,"ILE A 369;VAL A 377;ALA A 389;LYS A 391;MET A 438;GLY A 441;LEU A 489;SER A 499","None","0.89A","6fnmA-1snxA:24.9","6fnmA-1snxA:38.38"],["6HD4_A_STIA604_1","TYROSINE-PROTEIN KINASE ABL1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"VAL A 409;PHE A 437;MET A 438;GLY A 441","None","0.72A","6hd4A-1snxA:29.5","6hd4A-1snxA:11.15"],["6HD4_B_STIB602_1","TYROSINE-PROTEIN KINASE ABL1","1snx","TYROSINE-PROTEIN KINASE ITK\/TSK","Homo sapiens",4,"VAL A 409;PHE A 437;MET A 438;GLY A 441","None","0.76A","6hd4B-1snxA:29.5","6hd4B-1snxA:11.15"]]